Photo
December 3, 2021
Auerbach
Stories this photo appears in:
Puma Wins 5-Year Extension of Patent on Main Breast Cancer Treatment Drug Nerlynx
Westwood-based Puma Biotechnology Inc. announced Nov. 23 that it has won from U.S. regulators a five-year extension on the patent for its breast cancer therapy Nerlynx.
